Skip to main content

Table 1 Summary of patients’ demographic and clinical characteristics

From: Facility-level intervention to improve attendance and adherence among patients on anti-retroviral treatment in Kenya—a quasi-experimental study using time series analysis

Characteristics of study population Experienced cohort 1 Newly treated cohort 2
(n = 1894) Intervention Control p-value Intervention Control p-value
  (n = 446) (n = 352)   (n = 520) (n = 576)  
Female (n = 1258) 289 (64.8%) 248 (70.5%) 0.0908 337 (64.8%) 384 (66.7%) 0.5171
Mean age (95% CI) 39.4 (38.3–40.5) 38 (37.1–38.9) 0.065 38.6 (37.7–39.5) 39.2 (38.4–40.1) 0.349
Marital status (%)
Single 72 (16.1%) 43 (12.2%) 0.1157 79 (15.2%) 79 (13.7%) 0.1987
Divorced/Widowed 119 (26.7%) 114 (32.4%) 140 (26.9%) 186 (32.3%)
Married 181 (40.6%) 159 (45.2%) 253 (48.7%) 268 (46.5%)
Weight at start of follow-up—mean (95% CI)
Male 58.5 (56.7,60.3) 58.3 (56.8,59.9) 0.8974 54.9 (53.5,56.3) 57.3 (56,58.5) 0.0144
Female 54.8 (53.5,56.0) 55 (53.9,56.1) 0.796 52.3 (51.1,53.5) 52.8 (51.7,53.8) 0.5529
WHO stage at ART initiation (%)
Stage 1 14 (3.1%) 46 (13.1%) <0.0001 50 (9.6%) 88 (15.3%) 0.0003
Stage 2 61 (13.7%) 84 (23.9%) 146 (28.1%) 199 (34.5%)
Stage 3 278 (62.3%) 172 (48.9%) 247 (47.5%) 224 (38.9%)
Stage 4 31 (7%) 22 (6.3%) 31 (6%) 21 (3.6%)
CD4 value at ART initiation—mean (95% CI)
CD4 value 293 (269.1,316.9) 334.3 (309.8,358.8) 0.0183 169.2 (154.5,183.9) 189.4 (176.1,202.7) 0.0466
Evidence of adherence counselling prior to ART initiation
Adherence counselling 387 (86.8%) 238 (67.6%) <0.0001 457 (87.9%) 401 (69.6%) < 0.0001
  1. *Missing data: marital status n = 201; WHO staging n = 180; initial CD4 n = 470; initial adherence counseling n = 3.
  2. NB: Figures in bold show significant differences.